News Archive - Page 22 of 98 - Life Sciences Scotland

Clear

NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer

NuCana plc (NASDAQ: NCNA) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the...

13th Jun 2019

UK Steel Enterprise seals deal with Scots firm Antibody Analytics

UK Steel Enterprise has provided more than £100 million of financial support to aspiring businesses across the UK following its...

13th Jun 2019

Scottish Pavilion at MEDICA – Recruitment now open

MEDICA 2019 Nov 18 – Nov 21, 2019 Messe Dusseldorf, Germany Scottish Development International will once again be organising a...

12th Jun 2019

Scotland remains leading UK location outside London for global investment

Paul Lewis, Managing Director, Scottish Development International, comments on the findings of the latest EY Scotland Attractiveness Survey. “The latest EY...

4th Jun 2019

Gene-edited chicken cells resist bird flu virus

Scientists have used gene-editing techniques to stop the bird flu virus from spreading in chicken cells grown in the lab....

4th Jun 2019

Secretary of State for Health and Social Care visits next generation MRI scanners

Secretary of State for Health and Social Care, Matt Hancock, visited the University of Aberdeen to see first-hand the development...

3rd Jun 2019

Learn About Our Key Subsectors

Do you have news for the Scottish Life Sciences Community?

Submit Your Own News